Microba Life Sciences Limited - MAP share price
About
Microba Life Sciences Limited is an Australia-based precision microbiome company. The Company's therapeutic discovery is engaged in generating multiple potent therapeutic candidates to address unmet clinical needs for multiple chronic diseases, leveraging the biology of the healthy human gut microbiome. The Company offers a range of platforms, such as an Analysis Platform, Discovery Platform, and Therapeutic Platform. The Company uses advanced metagenomic sequencing technology and proprietary bioinformatics tools and provides precise and comprehensive measurements of the human gut microbiome. The Company's discovery platform enables partners to access this databank for the data-driven discovery of product opportunities. The Company's therapeutic platform is a repeatable platform for microbial therapeutic leads. The Company offers research services for clinical trials for biomarker discovery for nutritional therapies.
Company Profile
Disclaimer: The above financial data is sourced from EODHD and is for informational purposes only. Veye does not guarantee the accuracy or completeness of this data. Investors should conduct their own research and consult with a financial advisor before making investment decisions.
Price Summary
Price Chart
Get Your FREE Report
Discover the Top ASX Stocks to Invest In 2026!
Expert Analysis of Top-Performing ASX Stocks
Market Insights and In-Depth Research
Buy, Sell, And Hold Recommendations
Almost There!
Enter your details to download the report
Success!
Preparing your download...
Latest Reports from Veye
Grab Your FREE Report on Top 5 ASX Stocks to Buy in 2026
Latest Article